PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...

PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...

PORT WASHINGTON, New York, Nov. 27, 2018 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced it will ...

Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...

Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...

NEW YORK, Sept. 8, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese ...

Nordic Capital to Advance Achievement of Equashield Strategic Objective of Global Leadership in Hazardous Drug Handling Solutions PORT WASHINGTON, N.Y. , Oct. 7, 2022 /PRNewswire/ -- , a leading ...

Distribution expansion marks shift to clinically-proven safety provisions for nurses and pharmacists in burgeoning Hong Kong market Equashield (http://www.equashield ...

Partnership with Saudi Arabia-based Max Care Medical to promote safe handling practice for cytotoxics at upcoming regional conferences: 5th Annual GCC Pharmacy Congress and 4th IVPN Symposium ...

CellSHIELD ® addresses critical challenges in cell and gene therapy manufacturing by reducing cost, improving efficiency, and supporting product safety. Its fully closed design ensures sterility and ...